Cannabinoid-based sleep aids with independent sleep-study backing.
Sleep Providers, Reviewed
Sleep-focused telehealth providers offer evidence-based supplementation and clinician-prescribed alternatives.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
§ Medication Guides
Online Sleep Treatment: From Melatonin to Prescription Sleep Aids
Chronic insomnia affects approximately 10–15% of adults and is associated with increased risk of cardiovascular disease, metabolic syndrome, depression, and cognitive decline. First-line treatment is Cognitive Behavioural Therapy for Insomnia (CBT-I), which has demonstrated superiority to sleep medication in long-term outcomes. Telehealth platforms increasingly offer digital CBT-I programs alongside pharmacological options.
Pharmacological sleep aids range from over-the-counter melatonin and magnesium to prescription medications including suvorexant (Belsomra), lemborexant (Dayvigo), and low-dose doxepin. Melatonin is most effective for circadian rhythm disorders (jet lag, shift work) rather than primary insomnia. Prescription orexin receptor antagonists (suvorexant, lemborexant) have a more favourable safety profile than traditional benzodiazepines and Z-drugs.
Sleep-focused telehealth is a small but growing category. Most platforms offer a combination of supplementation protocols, digital CBT-I, and prescription access where appropriate. The evidence base for telehealth-delivered CBT-I is strong — multiple RCTs demonstrate equivalence to in-person CBT-I.
All Sleep Providers
Multi-category online men’s-health platform with ED plans from $20–$90/month and separately priced TRT care.
Sleep: What the Studies Show
Sleep treatment evidence varies by intervention. CBT-I has the strongest evidence base. Prescription sleep aids are appropriate for short-term use or specific clinical situations.
| Endpoint | Finding |
|---|---|
| CBT-I vs medication (meta-analysis)1 | CBT-I superior to sleep medication for long-term insomnia outcomes; remission rates 40–60% vs 20–30% for medication |
| Digital CBT-I efficacy2 | Digital CBT-I reduces sleep onset latency by 20 minutes and improves sleep efficiency by 10% vs waitlist control |
| Melatonin for sleep onset3 | Melatonin reduces sleep onset latency by 7.1 minutes (95% CI 4.4–9.8) in meta-analysis of 19 RCTs |
| Suvorexant vs placebo4 | Suvorexant 20 mg significantly improved sleep onset and maintenance vs placebo in Phase 3 trials; no next-day impairment at approved doses |
- Trauer JM et al. CBT-I meta-analysis. Ann Intern Med 2015 · Trauer JM et al. Cognitive Behavioral Therapy for Chronic Insomnia. Ann Intern Med. 2015;163:191-204.
- Digital CBT-I RCT. JAMA Intern Med 2016 · Espie CA et al. Effect of Digital Cognitive Behavioral Therapy for Insomnia on Health, Psychological Well-being, and Sleep-Related Quality of Life. JAMA Intern Med. 2019;179:1683-1692.
- Brzezinski A et al. Melatonin meta-analysis. Sleep Med Rev 2005 · Brzezinski A et al. Effects of Exogenous Melatonin on Sleep: A Meta-Analysis. Sleep Med Rev. 2005;9:41-50.
- Herring WJ et al. Suvorexant. Neurology 2012 · Herring WJ et al. Suvorexant in Patients with Insomnia. Neurology. 2012;79:2265-2274.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.
Sleep Telehealth: Common Questions
Frequently Asked Questions
What is the best treatment for chronic insomnia?
Cognitive Behavioural Therapy for Insomnia (CBT-I) is the first-line treatment recommended by the American Academy of Sleep Medicine. It is more effective than sleep medication in the long term and has no side effects. Digital CBT-I programs delivered via app or telehealth are as effective as in-person CBT-I. Medication is appropriate for short-term use or as an adjunct to CBT-I.
Does melatonin work for insomnia?
Melatonin is most effective for circadian rhythm disorders (jet lag, delayed sleep phase syndrome) rather than primary insomnia. For insomnia, the evidence is modest — melatonin reduces sleep onset latency by approximately 7 minutes on average in meta-analyses. It is safe for short-term use and has minimal side effects. Doses of 0.5–1 mg are as effective as higher doses for most people.
Are prescription sleep aids safe for long-term use?
Traditional benzodiazepines and Z-drugs (zolpidem, eszopiclone) carry risks of dependence, tolerance, and rebound insomnia with long-term use. Newer orexin receptor antagonists (suvorexant, lemborexant) have a more favourable long-term safety profile with lower dependence risk. Low-dose doxepin is FDA-approved for sleep maintenance insomnia and is non-habit-forming.
How much does online sleep treatment cost?
Supplementation-focused programs start at $37–$99/month. Platforms that include digital CBT-I programs cost $50–$150/month. Prescription sleep medication through telehealth adds the cost of the consultation ($50–$100 one-time or monthly subscription) plus medication cost ($10–$50/month for generics).
For sleep, editors look at the evidence behind each offered protocol, the mix of behavioral and prescription options, and pricing clarity. Default order: providers with an eligible affiliate offer are listed first; within each group, order follows a 50/50 composite of our manual value score and a review-count-adjusted Trustpilot score, with trust and experience scores breaking ties. Scores are editorial judgments, not clinical assessments, and price checks are dated where shown.
Full methodology →We use Google Analytics 4 to understand how readers find and use RxNotebook. Analytics cookies are only set with your consent. We do not use advertising cookies. See our Cookie Policy and Privacy Policy for details.